Evidence check: AMH in the context of skin aging

AMH (Anti-Müllerian Hormone) is a well-established biomarker for ovarian reserve, not for skin aging. The idea that AMH relates to skin aging stems from the observation that menopause—and thus declining AMH levels—coincides with accelerated skin aging. However, there are no direct, robust studies proving AMH as an independent predictor of skin aging. Skin aging is driven by UV exposure, collagen breakdown, oxidative stress, genetics, and lifestyle factors—not by AMH alone. A few small studies show weak correlations between AMH and skin elasticity, but the evidence is mechanistic and unreplicated. Consumers should understand: an AMH test does not inform skin health. Those wanting to measure or influence skin aging should look at validated markers like skin hydration, wrinkle analysis, or collagen degradation products. Claims that AMH is a 'skin aging marker' are currently marketing, not science.